PHIO PHARMACEUTICALS CORP. Preferred Stock Dividends and Other Adjustments
PHIO PHARMACEUTICALS CORP. (PHIO) reported Preferred Stock Dividends and Other Adjustments of $700.00 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2014-11-13
- PHIO PHARMACEUTICALS CORP. preferred stock dividends and other adjustments for the quarter ending 2014-09-30 was $700.00K, a 51.62% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. preferred stock dividends and other adjustments for the quarter ending 2014-06-30 was $1.21M, a 49.44% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. preferred stock dividends and other adjustments for the quarter ending 2014-03-31 was $1.75M, a 50.52% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. preferred stock dividends and other adjustments for the quarter ending 2013-12-31 was $1.22M, a 32.57% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. preferred stock dividends and other adjustments for fiscal 2013 was $8.61M, a 32.81% decline from fiscal 2012.
- PHIO PHARMACEUTICALS CORP. preferred stock dividends and other adjustments for fiscal 2012 was $12.81M.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 3 month as first filed | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 6 month as first filed | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month | Preferred Stock Dividends and Other Adjustments 114 month | Preferred Stock Dividends and Other Adjustments 117 month | Preferred Stock Dividends and Other Adjustments 120 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $700.00K 10-Q · filed 2014-11-13 | $1.91M derived: sum of 2 quarters · filed 2014-11-13 | $3.67M 10-Q · filed 2014-11-13 | $4.88M derived: sum of 4 quarters · filed 2014-11-13 | |||||
| 2014-06-30 | $1.21M 10-Q · filed 2014-08-14 | $2.97M 10-Q · filed 2014-08-14 | $4.18M derived: sum of 3 quarters · filed 2014-08-14 | $5.63M derived: sum of 4 quarters · filed 2014-11-13 | |||||
| 2014-03-31 | $1.75M 10-Q · filed 2014-05-14 | $2.97M derived: sum of 2 quarters · filed 2014-05-14 | $4.42M derived: sum of 3 quarters · filed 2014-11-13 | $6.82M derived: sum of 4 quarters · filed 2014-11-13 | |||||
| 2013-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.66M derived: sum of 2 quarters · filed 2014-11-13 | $5.06M derived: sum of 3 quarters · filed 2014-11-13 | $8.61M 10-K · filed 2014-03-28 | |||||
| 2013-09-30 | $1.45M 10-Q · filed 2014-11-13 | $3.85M derived: sum of 2 quarters · filed 2014-11-13 | $7.39M 10-Q · filed 2014-11-13 | $8.31M derived: sum of 4 quarters · filed 2014-11-13 | |||||
| 2013-06-30 | $2.40M 10-Q · filed 2014-08-14 | $5.95M 10-Q · filed 2014-08-14 | $6.86M derived: sum of 3 quarters · filed 2014-08-14 | $8.14M derived: sum of 4 quarters · filed 2014-08-14 | |||||
| 2013-03-31 | $3.55M 10-Q · filed 2014-05-14 | $4.46M derived: sum of 2 quarters · filed 2014-05-14 | $5.74M derived: sum of 3 quarters · filed 2014-05-14 | $16.36M derived: sum of 4 quarters · filed 2014-05-14 | |||||
| 2012-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.19M derived: sum of 2 quarters · filed 2014-03-28 | $12.81M derived: sum of 3 quarters · filed 2014-03-28 | $12.81M 10-K · filed 2014-03-28 | $12.81M 10-K · filed 2013-03-29 | ||||
| 2012-09-30 | $1.28M 10-Q · filed 2013-11-14 | $11.90M derived: sum of 2 quarters · filed 2013-11-14 | $11.90M 10-Q · filed 2013-11-14 | $11.90M 10-Q · filed 2012-11-13 | |||||
| 2012-06-30 | $10.62M 10-Q · filed 2013-08-14 | -$9.62M 10-Q · filed 2012-08-14 | $10.62M 10-Q · filed 2013-08-14 | -$9.62M 10-Q · filed 2012-08-14 | -$9.62M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |